Lens combines diffractive multifocal and extended depth-of-focus properties.
Ophthalmology Times: November 15, 2021
New acrylic implant provides option for patients with endothelial dysfunction.
Product stimulates basal tear production, restores tear film homeostasis, and relieves symptoms.
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
First patient treated in ViaLase’s IDE trial
2
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
3
Formosa Pharmaceuticals and Rxilient sign licensing and commercialization agreement for APP13007
4
Inflammasome Therapeutics completes phase 2 trial enrollment for K8 in GA
5
.png "Optometry Times"){kind=logo}
